Heart disease, stroke, and other cardiovascular diseases cause one-third of all deaths in the United States,1 with stroke alone as
Read more“Response by Loyaga-Rendon et al to Letter Regarding Article, “Extracorporeal Membrane Oxygenation as a Bridge to Durable Mechanical Circulatory Support:
Read moreBiomedical innovation in cardiovascular care is important given the significant burden of cardiovascular diseases (CVDs) in America. Over 18 million
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/7″>Volume 13, Issue 7</a>, July 1, 2020. Source link
Read moreAfter decades of progress, there is a renewed need to improve the quality of cardiovascular care due to slipping cardiovascular
Read moreWhat Is Known Both stroke survivors and care partners have been found to experience high levels of depressive symptomatology. Depressive
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/6″>Volume 13, Issue 6</a>, June 1, 2020. Source link
Read moreBackground: Many large-scale cardiovascular clinical trials are plagued with escalating costs and low enrollment. Implementing a computable phenotype, which is
Read moreWhat Is New? Anecdotally, most clinicians have noted a decline in the number of patients seeking medical care for non-coronavirus
Read more“Letter by Gattellari and Worthington Regarding Article, “Deriving a Passive Surveillance Stroke Severity Indicator From Routinely Collected Administrative Data: The
Read more
